Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

A new drug, FLAV-27, targets epigenetic changes in Alzheimer’s. In preclinical studies, the drug reduced levels of ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

At DevSparks 2026 in Pune, Gaurav Tripathi, Co-founder and Group CTO at Partex.AI, shared how federated learning, knowledge ...

Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or ...

He has completed his academic career by finishing his PhD, flying back to Germany with his dad, and preparing for his next educational pursuit. This time, he will be studying medical science with a ...

The public health institute’s FOIA office had lost too many staff members to fulfill public record requests - falling victim to President Donald Trump’s executive order to eliminate “waste, bloat, and ...

At Advanced Therapies, investors noted that early planning, adaptability and building trust will help a biotech startup succeed.

A recent study shows that combining magnetic brain scans with computer models can safely measure how dementia medications affect living human brains. This approach could replace invasive tests and ...

I t was December 2025, and Katie Tobin’s kids were fighting again. This time it was because her six-year-old, Tori, wasn’t ...

The researchers found higher ATF4 levels in tumors from older subjects, both in mice and in human patients. Elevated ATF4 was also linked to a greater chance of cancer returning after lung surgery and ...

Clinical research organization uses AI agent-driven knowledge platform built on a unified contextual data layer to identify higher-performing trial sites faster and minimize inclusion of costly ...